HC Wainwright & Co.:维持OnKure Therapeutics评级

证券之星
18 Mar

HC Wainwright&Co.:维持OnKure Therapeutics(OKUR.US)评级,由买入调整至买入评级,目标价由40.00美元调整至34.00美元。OnKure Therapeutics(OKUR.US)公司简介:OnKure Therapeutics Inc是一家处于临床阶段的生物制药公司,致力于发现和开发顶级精准药物,靶向现有疗法无法治疗的,经生物学验证的癌症驱动因素。该...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10